UNSPSC 51293102: Iproclozide
Commodity
Code facts
- Part of
-
-
51000000
-
51290000
- 51293100
-
51290000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51293102
Definition
This classification denotes a monoamine oxidase inhibitor and antidepressant agent with the molecular formula C11H15ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1II9D6CB3J, chemically known as acetic acid, (p-chlorophenoxy)-, 2-isopropylhydrazide but generally known as iproclozide, which bears US NIH Compound Identifier 19063. European Medicines Agency schedules Iproclozide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08280MIG.
Read the full definition
The term IPROCLOZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules iproclozide in its Anatomical Therapeutic Chemical (ATC) Classification. IPROCLOZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iproclozide under HS 29280090 and SITC 51486. As of Q4 2014, IPROCLOZIDE remains the US FDA Preferred Term for this commodity. Iproclozide bears US NLM identifiers UMLS ID C0063841 and NCI Concept Code C65955.
SMILES: CC(C)NNC(=O)COC1=CC=C(C=C1)Cl.
About UNSPSC 51293102
UNSPSC 51293102 Iproclozide, a Commodity code, reflects state and local procurement of pharmaceutical and medical products for public health and emergency response. The recent activity under this code centers on naloxone and drug deactivation systems purchased by local health authorities to support community health and overdose-response initiatives. State and local governments use this code to procure pharmaceutical supplies and related medical equipment that serve public health missions, including opioid-overdose intervention and controlled-substance management programs. Issuing bodies soliciting under the code include county health departments and community health authorities operating through competitive sealed-bid processes.
Seminole County, Florida represents the primary recent activity under this code. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB process, with a response deadline of July 26, 2023. The contract includes an initial two-year term with an option for a one-year renewal and requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include shipping and delivery costs in their proposals, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify requirements. The procurement is potentially funded through FEMA, which introduces federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. A three-month probationary period allows the county to terminate with or without cause during the initial phase.
Quick answers
What is UNSPSC 51293102?
UNSPSC 51293102 is Iproclozide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51293102?
UNSPSC 51293102 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51293102
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code